文章摘要
卢燕,王晶璞,刘莉红,冯克娜,郑美斯.利拉鲁肽对初诊肥胖2型糖尿病患者成纤维细胞生长因子 21和调节性T细胞及血清肝酶的影响[J].中国临床保健杂志,2019,22(4):492-495.
利拉鲁肽对初诊肥胖2型糖尿病患者成纤维细胞生长因子 21和调节性T细胞及血清肝酶的影响
Effects of liraglutide on FGF-21,regulatory T cells and serum hepatic enzymes in newly diagnosed obese type 2 diabetes mellitus
投稿时间:2018-12-20  
DOI:10.3969/J.issn.1672-6790.2019.04.016
中文关键词: 糖尿病, 2型  肥胖症  利拉鲁肽  成纤维细胞生长因子  T淋巴细胞, 调节性
英文关键词: Diabetes mellitus, type 2  Obesity  Liraglutide  Fibroblast growth factors  T-lymphocytes, regulatory 〖FL
基金项目:河北省保定市科学研究与发展计划项目(20170254)
作者单位E-mail
卢燕 河北保定市第二医院内分泌科,,071051 zyy666hb@163.com 
王晶璞 河北保定市第二医院内分泌科,,071051  
刘莉红 河北保定市第二医院核医学科,071051  
冯克娜 河北保定市第二医院内分泌科,,071051  
郑美斯 河北保定市第二医院内分泌科,,071051  
摘要点击次数: 372
全文下载次数: 234
中文摘要:
      目的 探讨分析利拉鲁肽治疗对初诊肥胖2型糖尿病患者成纤维细胞生长因子 21(FGF-21)、调节性T细胞及血清肝酶的影响。方法 选择门诊诊断的81例初诊肥胖2型糖尿病患者,将其按照随机数字表法分为观察组41例、对照组40例。对照组给予二甲双胍治疗,观察组在对照组基础上给予利拉鲁肽,两组连续治疗16周。比较两组患者治疗前后血糖、体质指数变化情况,血浆FGF-21水平、外周血CD4+CD25+Foxp3+Treg细胞比例以及血清肝酶指标变化。结果 两组患者治疗后体质指数及血糖均显著降低(P<0.05),且观察组降低程度更为显著(P<0.05)。治疗后两组患者外周血FGF-21水平、血清肝酶水平均显著降低(P<0.05),且治疗后观察组患者外周血FGF-21水平、血清肝酶水平均显著低于对照组(P<0.05)。治疗后两组患者CD4+CD25+Foxp3+Treg细胞比例较治疗前显著升高(P<0.05),且治疗后观察组患者CD4+CD25+Foxp3+Treg细胞比例显著高于对照组(P<0.05)。结论 利拉鲁肽治疗初诊肥胖2型糖尿病可有效降低FGF-21水平、提高调节T细胞比例以及降低血清肝酶水平。
英文摘要:
      Objective To investigate the effects of liraglutide on FGF-21,regulatory T cells and serum liver enzymes in newly diagnosed obese type 2 diabetic patients.Methods 81 newly diagnosed obese patients with type 2 diabetes mellitus were randomly divided into observation group (41 cases) and control group (40 cases).The control group was treated with metformin.The observation group was treated with liraglutide on the basis of the control group.The two groups were treated continuously for 16 weeks.The changes of blood glucose,body mass index,plasma FGF-21 level,peripheral blood CD4+CD25+Foxp3+Treg cell ratio and serum hepatic enzyme index were compared between the two groups before and after treatment.Results BMI and blood glucose of the two groups were significantly decreased after treatment (P<0.05),and the observation group was significantly lower than the control group (P<0.05).After treatment,the levels of peripheral blood FGF-21 and serum liver enzymes in the two groups were significantly lower than those in the control group (P<0.05),and the levels of peripheral blood FGF-21 and serum liver enzymes in the observation group were significantly lower than those in the control group (P<0.05).After treatment,the ratio of CD4+CD25+Foxp3+Treg cell the two groups was significantly higher than that before treatment (P<0.05),and the observation group was significantly higher than that of the control group (P<0.05).Conclusion Liraglutide can effectively decrease level of FGF-21,increase the proportion of T cells and decrease the level of serum liver enzymes.
查看全文     下载PDF阅读器
关闭
分享按钮